AstraZeneca (AZN) Announces SIROCCO, CALIMA Trials Met Primary, Key Secondary Endpoints
Go back to AstraZeneca (AZN) Announces SIROCCO, CALIMA Trials Met Primary, Key Secondary Endpoints| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 71.20 +0.35 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.85 | 52 Week High | $35.04 | |||
| Open | $71.41 | 52 Week Low | $26.97 | |||
| Day High | $71.47 | P/E | N/A | |||
| Day Low | $70.69 | EPS | $0.00 | |||
| Volume | 6,137,009 | |||||
| Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) | Delayed: 14.60 -0.19 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.79 | 52 Week High | $18.64 | |||
| Open | $14.79 | 52 Week Low | $12.59 | |||
| Day High | $14.96 | P/E | N/A | |||
| Day Low | $14.60 | EPS | $0.00 | |||
| Volume | 111,219 | |||||
